Several studies have investigated the relationship between C-reactive protein (CRP) and serum lipid levels in Major Depression (MD), but no study has, to date, evaluated the impact of alexithymia on these parameters. Therefore, the aim of the present cross-sectional study was to evaluate the relationship between alexithymia, suicide risk, C-reactive protein (CRP) and serumlipid levels in adult outpatients suffering frommoderate to severe MD. CRP and serumlipid levels datawere analyzed in 145 drug-naïve adult outpatients (69men, 76women) with a DSM-IV diagnosis of MD. Alexithymia was measured with the 20-item Toronto Alexithymia Scale (TAS-20), depression severity was evaluated with the 17-item Hamilton Depression Rating Scale (HAM-D) and suicide risk was determined using the Scale of Suicide Ideation (SSI). Alexithymics showed altered serum lipid levels and higher CRP than non-alexithymics. In the linear regressionmodels, lower total cholesterol levels and “Difficulty in Identifying Feelings” dimension of TAS-20were significantly associatedwith depression severity, whereas lower high-density lipoprotein levels and “Difficulty in Identifying and Describing Feelings” dimensions of TAS-20were associated with higher suicide risk. Authors discuss study limitations and future research needs.

Alexithymia and its relationships with C-reactive protein and serum lipid levels among drug naive adult outpatients with major depression

DE BERARDIS, Domenico;GAMBI, Francesco;CONTI, CHIARA;SEPEDE, GIANNA;FULCHERI, Mario;SALERNO, Rosa Maria;
2008-01-01

Abstract

Several studies have investigated the relationship between C-reactive protein (CRP) and serum lipid levels in Major Depression (MD), but no study has, to date, evaluated the impact of alexithymia on these parameters. Therefore, the aim of the present cross-sectional study was to evaluate the relationship between alexithymia, suicide risk, C-reactive protein (CRP) and serumlipid levels in adult outpatients suffering frommoderate to severe MD. CRP and serumlipid levels datawere analyzed in 145 drug-naïve adult outpatients (69men, 76women) with a DSM-IV diagnosis of MD. Alexithymia was measured with the 20-item Toronto Alexithymia Scale (TAS-20), depression severity was evaluated with the 17-item Hamilton Depression Rating Scale (HAM-D) and suicide risk was determined using the Scale of Suicide Ideation (SSI). Alexithymics showed altered serum lipid levels and higher CRP than non-alexithymics. In the linear regressionmodels, lower total cholesterol levels and “Difficulty in Identifying Feelings” dimension of TAS-20were significantly associatedwith depression severity, whereas lower high-density lipoprotein levels and “Difficulty in Identifying and Describing Feelings” dimensions of TAS-20were associated with higher suicide risk. Authors discuss study limitations and future research needs.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/155471
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 61
social impact